Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2014, Article ID 650916, 4 pages
http://dx.doi.org/10.1155/2014/650916
Case Report

Clinical and Imaging Resolution of Neonatal Hemochromatosis following Treatment

1Neonatal Intensive Care Unit, Schneider Children’s Medical Center of Israel, 14 Kaplan Street, 49202 Petah Tikva, Israel
2The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
3Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
4Radiology Department, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel

Received 14 January 2014; Revised 31 May 2014; Accepted 7 June 2014; Published 24 June 2014

Academic Editor: Ricardo J. Dinis-Oliveira

Copyright © 2014 Ayelet Machtei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Rodrigues, M. Kallas, R. Nash et al., “Neonatal hemochromatosis—medical treatment vs. transplantation: the King's experience,” Liver Transplantation, vol. 11, no. 11, pp. 1417–1424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Flynn, N. Mohan, P. McKiernan et al., “Progress in treatment and outcome for children with neonatal haemochromatosis,” Archives of Disease in Childhood Fetal and Neonatal Edition, vol. 88, no. 2, pp. F124–F127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Kelly, P. W. Lunt, F. Rodrigues et al., “Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism,” Journal of Medical Genetics, vol. 38, no. 9, pp. 599–610, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Whitington and J. U. Hibbard, “High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis,” The Lancet, vol. 364, pp. 1690–1698, 2004. View at Google Scholar
  5. M. E. Blohm, D. Vesterling-Hörner, G. Calaminus, and U. Göbel, “Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age,” Pediatric Hematology and Oncology, vol. 15, no. 2, pp. 135–142, 1998. View at Publisher · View at Google Scholar
  6. A. Verloes, I. K. Temple, A. Hubert et al., “Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers,” Journal of Medical Genetics, vol. 33, no. 6, pp. 444–449, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Knisely, G. Mieli-Vergani, and P. Whitington, “Neonatal hemochromatosis,” Gastroenterology Clinics of North America, vol. 32, no. 3, pp. 877–889, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. P. F. Whitington and P. Malladi, “Neonatal hemochromatosis: is it an alloimmune disease?” Journal of Pediatric Gastroenterology and Nutrition, vol. 40, no. 5, pp. 544–549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Whitington, “Fetal and infantile hemochromatosis,” Hepatology, vol. 43, no. 4, pp. 654–660, 2006. View at Publisher · View at Google Scholar
  10. E. B. Rand, S. J. Karpen, S. Kelly et al., “Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin,” Journal of Pediatrics, vol. 155, no. 4, pp. 566–571, 2009. View at Publisher · View at Google Scholar
  11. E. Lopriore, M. L. Mearin, D. Oepkes, R. Devlieger, and P. Whitington, “Neonatal hemochromatosis: management, outcome, and prevention,” Prenatal Diagnosis, vol. 33, no. 13, pp. 1221–1225, 2013. View at Publisher · View at Google Scholar
  12. F. Babor, B. Hadzik, H. Stannigel, E. Mayatepek, and T. Hoehn, “Successful management of neonatal hemochromatosis by exchange transfusion and immunoglobulin: a case report,” Journal of Perinatology, vol. 33, no. 1, pp. 83–85, 2013. View at Publisher · View at Google Scholar · View at Scopus